StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) stock

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$78.94−5.84 (-6.89%)

Close on Nov 17, 2026Market cap $7.00BP/E –Yield –

CG Oncology total assets

Total assets on the balance sheet at the end of each period.

CG Oncology's total assets was $1.05B at Sep 30, 2026. For fiscal 2025 it was $791.59M, up 4.9% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$791.59M+4.9%
FY2024Dec 31, 2024$754.80M+278.7%
FY2023Dec 31, 2023$199.30M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.05B+43.4%
Q2 FY2026Jun 30, 2026$1.09B+54.8%
Q1 FY2026Mar 31, 2026$1.14B+55.9%
Q4 FY2025Dec 31, 2025$791.59M+4.9%
Q3 FY2025Sep 30, 2025$729.91M+32.1%
Q2 FY2025Jun 30, 2025$701.45M+24.3%
Q1 FY2025Mar 31, 2025$728.18M+25.7%
Q4 FY2024Dec 31, 2024$754.80M+278.7%
Q3 FY2024Sep 30, 2024$552.47M–
Q2 FY2024Jun 30, 2024$564.33M–
Q1 FY2024Mar 31, 2024$579.11M–
Q4 FY2023Dec 31, 2023$199.30M–

More CG Oncology figures

See a number that looks wrong?